ZBRA Earnings

ZBRA reported its earnings on 2026-02-12, showcasing a revenue of 1.48B against an estimate of 1.46B, resulting in a 1.03% surprise. The EPS was 4.33, surpassing the expected 4.33 by 0%. The stock experienced a 8.58% price change on the earnings day and a 0.01% change over the next five days, reflecting market reactions to the results.

Following ZBRA's earnings announcement on 2026-02-12, the stock price moved by 8.58% on the day of the release. Over the subsequent five days, it saw a 0.01% change. Historically, ZBRA's stock price tends to shift by an average of -1.65% in the 10 days leading up to earnings and 0.05% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ZBRA's annual revenue to reach 1.44B, while the EPS is projected at 4.10. These estimates reflect recent revisions, with revenue estimates revised downward by -0.01% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ZBRA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.01%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ZBRA's stock price typically moves by -1.65% in the 10 days before its earnings and 0.05% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 4.10 and revenue of 1.44B.

The earnings call presents a mixed picture. While there are positive elements like anticipated sales growth, strong adjusted EBITDA margin, and share repurchases, there are concerns such as accumulated debt, strategic review uncertainties, and issues in the Canadian legal business. The Q&A reveals potential risks, including competition and financial reporting challenges. However, the overall outlook remains stable with optimistic guidance and strategic initiatives, balancing out the negative aspects. Therefore, the stock price is likely to remain within a neutral range over the next two weeks.